Rare Disease Tests Aplenty On US FDA’s September User Fee Calendar

 
• By Bridget Silverman
  
About half of the US FDA's user fee goal dates in September 2025 are for rare conditions, a high priority of the agency's new leadership. (Shutterstock)

More from US FDA Performance Tracker

More from Regulatory Trackers